Exoxemis Inc
Biotechnology ResearchArkansas, United States2-10 Employees
Use of MPO and EPO enzyme effect to preferentially kill a broad range of pathogens, with little or new resistance response.
Innovative Technology Exoxemis Inc leverages unique enzyme effects to target a broad range of pathogens, offering potential for partnerships in the biotech or medical device sectors focused on antimicrobial solutions.
Niche Market Position With a specialized approach in pathogen control and a relatively low revenue base, there are opportunities to expand into clinical, healthcare, or environmental markets seeking novel antimicrobial technologies.
Growth Potential As a small company with a focus on innovative solutions, Exoxemis presents an opportunity for strategic investment or collaborations to accelerate product development and market entry.
Digital Presence The company's current tech stack includes modern web tools and cloud services, indicating readiness for digital marketing, online outreach, and potential software integrations in biotech solutions.
Research and Development Dedicated to pathogen research with minimal revenue, Exoxemis may benefit from R&D funding, grants, or partnerships with larger biotech firms aiming to enhance antimicrobial pipelines.
Exoxemis Inc uses 8 technology products and services including Cloudflare, Microsoft 365, Slick, and more. Explore Exoxemis Inc's tech stack below.
| Exoxemis Inc Email Formats | Percentage |
| FLast@exoxemis.com | 100% |
Biotechnology ResearchArkansas, United States2-10 Employees
Use of MPO and EPO enzyme effect to preferentially kill a broad range of pathogens, with little or new resistance response.
Exoxemis Inc's revenue is estimated to be in the range of $1M
Exoxemis Inc's revenue is estimated to be in the range of $1M